Literature DB >> 9854111

Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype typhimurium isolates from humans and animals.

C Heurtin-Le Corre1, P Y Donnio, M Perrin, M F Travert, J L Avril.   

Abstract

We determined the resistance to quinolone of 309 Salmonella enterica subsp. enterica serotype Typhimurium strains isolated from humans and animals (cattle, pigs, or poultry) in 1995 or 1996. Nalidixic acid resistance increased from 8.5% in 1995 to 18.6% in 1996. The highest resistance levels correlated with a mutation at Ser-83 (or Asp-82). All strains remained ciprofloxacin susceptible. Human and animal isolates were compared by pulsed-field gel electrophoresis, and the banding patterns of the human isolates most closely matched those of the bovine isolates.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9854111      PMCID： PMC84233     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  19 in total

1.  Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.

Authors:  S Ozeki; T Deguchi; M Yasuda; M Nakano; T Kawamura; Y Nishino; Y Kawada
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

2.  Restriction endonucleases for pulsed field mapping of bacterial genomes.

Authors:  M McClelland; R Jones; Y Patel; M Nelson
Journal:  Nucleic Acids Res       Date:  1987-08-11       Impact factor: 16.971

3.  Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis.

Authors:  F J Vasallo; P Martín-Rabadán; L Alcalá; J M García-Lechuz; M Rodríguez-Créixems; E Bouza
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

4.  Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.

Authors:  M K Glynn; C Bopp; W Dewitt; P Dabney; M Mokhtar; F J Angulo
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

5.  Acalculous nontyphoidal salmonellal cholecystitis requiring surgical intervention despite ciprofloxacin therapy: report of three cases.

Authors:  B McCarron; W C Love
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

6.  Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.

Authors:  J Wain; N T Hoa; N T Chinh; H Vinh; M J Everett; T S Diep; N P Day; T Solomon; N J White; L J Piddock; C M Parry
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

7.  Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis.

Authors:  D C Schwartz; C R Cantor
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

8.  Increasing incidence of resistance to trimethoprim and ciprofloxacin in epidemic Salmonella typhimurium DT104 in England and Wales.

Authors:  E.J. Threlfall; L.R. Ward; B Rowe
Journal:  Euro Surveill       Date:  1997-11

9.  Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.

Authors:  S Ouabdesselam; D C Hooper; J Tankovic; C J Soussy
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

10.  Emerging quinolone-resistant Salmonella in the United States.

Authors:  H Herikstad; P Hayes; M Mokhtar; M L Fracaro; E J Threlfall; F J Angulo
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883
View more
  6 in total

1.  Molecular characterization of Irish Salmonella enterica serotype typhimurium: detection of class I integrons and assessment of genetic relationships by DNA amplification fingerprinting.

Authors:  M Daly; J Buckley; E Power; C O'Hare; M Cormican; B Cryan; P G Wall; S Fanning
Journal:  Appl Environ Microbiol       Date:  2000-02       Impact factor: 4.792

2.  Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

Authors:  Frank Møller Aarestrup; Camilla Wiuff; Kåre Mølbak; E John Threlfall
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

3.  Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.

Authors:  E Giraud; A Cloeckaert; D Kerboeuf; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

4.  Multiple genetic typing of Salmonella enterica serotype typhimurium isolates of different phage types (DT104, U302, DT204b, and DT49) from animals and humans in England, Wales, and Northern Ireland.

Authors:  Ernesto Liebana; Lourdes Garcia-Migura; Carol Clouting; Felicity A Clifton-Hadley; Elisabeth Lindsay; E John Threlfall; Stanley W J McDowell; Robert H Davies
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

5.  Comparison of gyrA mutations, cyclohexane resistance, and the presence of class I integrons in Salmonella enterica from farm animals in England and Wales.

Authors:  Ernesto Liebana; Carol Clouting; Claire A Cassar; Luke P Randall; Rachel A Walker; E John Threlfall; Felicity A Clifton-Hadley; Anne M Ridley; Robert H Davies
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

6.  Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.

Authors:  J M Ling; E W Chan; A W Lam; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.